Pre-Open Stock Movers 12/27: (FLXN) (RAD) (SPPI) (QGEN) (RH)

December 27, 2019 8:46 AM EST

Pre-Open Movers

Flexion Therapeutics (NASDAQ: FLXN) +20%; announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the product label for ZILRETTA (triamcinolone acetonide extended-release injectable suspension) for the treatment of osteoarthritis (OA) knee pain.

Rite Aid (NYSE: RAD) +11%; extends intraday gain of 19% in post-market trading.

Spectrum Pharma (NASDAQ: SPPI) +4.9%; declined 60% yesterday.

Qiagen (NYSE: QGEN) +2%; deal near to mid-term still highly likely - sources

RH (NYSE: RH) -2.5%



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Special Reports

Related Entities

Pre Market Movers, FDA